| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.5 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.056 | 0.5 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.5 |